Skip to content

Clinical trials

Psychotic Disorders trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Sweden Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20071
20081
20111
20141
20191
20201
20212
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status3
Terminated2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet3
Region Örebro County2
Umeå University2
Uppsala University2
AstraZeneca1
Eli Lilly and Company1
Göteborg University1
Janssen-Cilag International NV1
Uppsala University Hospital1
Vardalinstitutet The Swedish Institute for Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders16
Schizophrenia6
Mental Disorders4
Schizophrenia Spectrum and Other Psychotic Disorders2
Antisocial Personality Disorder1
Autistic Disorder1
Bipolar Disorder1
Metabolic Syndrome1
Mood Disorders1
Obsessive-Compulsive Disorder1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.